Epinephrine
ApprovedRecruiting 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Cardiac Arrest, Out-Of-Hospital
Conditions
Cardiac Arrest, Out-Of-Hospital, Sudden Cardiac Arrest, Ventricular Fibrillation, Ventricular Tachycardia-Pulseless
Trial Timeline
May 24, 2023 → Dec 1, 2028
NCT ID
NCT03826524About Epinephrine
Epinephrine is a approved stage product being developed by Pfizer for Cardiac Arrest, Out-Of-Hospital. The current trial status is recruiting. This product is registered under clinical trial identifier NCT03826524. Target conditions include Cardiac Arrest, Out-Of-Hospital, Sudden Cardiac Arrest, Ventricular Fibrillation.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03826524 | Approved | Recruiting |
Competing Products
20 competing products in Cardiac Arrest, Out-Of-Hospital